HTLV-III SEROPOSITIVITY IN EUROPEAN HAEMOPHILIACS EXPOSED TO FACTOR VIII CONCENTRATE IMPORTED FROM THE USA
- 29 December 1984
- journal article
- case report
- Published by Elsevier in The Lancet
- Vol. 324 (8417-8418), 1444-1446
- https://doi.org/10.1016/s0140-6736(84)91632-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome.BMJ, 1984
- PREVALENCE OF ANTIBODY TO HUMAN T-LYMPHOTROPIC VIRUS TYPE III IN AIDS AND AIDS-RISK PATIENTS IN BRITAINThe Lancet, 1984
- ANTIBODY TO LYMPHADENOPATHY-ASSOCIATED VIRUS IN HAEMOPHILIACS WITH AND WITHOUT AIDSThe Lancet, 1984
- HIGH PREVALENCE OF LYMPHADENOPATHY VIRUS (LAV) IN EUROPEAN HAEMOPHILIACSThe Lancet, 1984
- ACQUIRED IMMUNODEFICIENCY SYNDROME AND OTHER POSSIBLE IMMUNOLOGICAL DISORDERS IN EUROPEAN HAEMOPHILIACSThe Lancet, 1984
- Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDSScience, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?BMJ, 1983
- T-Lymphocyte Subpopulations in Patients with Classic Hemophilia Treated with Cryoprecipitate and Lyophilized ConcentratesNew England Journal of Medicine, 1983
- Impaired Cell-Mediated Immunity in Patients with Classic HemophiliaNew England Journal of Medicine, 1983